Correction: Inflammatory and tolerogenic myeloid cells determine outcome following human allergen challenge.

Autor: Voskamp AL, Tak T, Gerdes ML, Menafra R, Duijster E, Jochems SP, Kielbasa SM, Kormelink TG, Stam KA, van Hengel ORJ, de Jong NW, Hendriks RW, Kloet SL, Yazdanbakhsh M, de Jong EC, Gerth van Wijk R, Smits HH
Jazyk: angličtina
Zdroj: The Journal of experimental medicine [J Exp Med] 2023 Sep 04; Vol. 220 (9). Date of Electronic Publication: 2023 Aug 18.
DOI: 10.1084/jem.2022111108162023c
Databáze: MEDLINE